Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
3.120
-0.100 (-3.11%)
Mar 9, 2026, 1:02 PM EDT - Market open
Evaxion Market Cap
Evaxion has a market cap or net worth of $26.02 million as of March 9, 2026. Its market cap has increased by 56.11% in one year.
Market Cap
26.02M
Enterprise Value
11.13M
1-Year Change
56.11%
Ranking
Category
Stock Price
$3.12
Market Cap Chart
Since the IPO on February 5, 2021, Evaxion's market cap has decreased from $191.99M to $26.02M, a decrease of -86.45%. That is a compound annual growth rate of -32.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 26.86M | -32.49% |
| Dec 31, 2025 | 39.78M | 702.21% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dyadic International | 27.78M |
| Kyntra Bio | 27.71M |
| BriaCell Therapeutics | 27.53M |
| IGC Pharma | 27.39M |
| Cue Biopharma | 27.35M |
| Passage Bio | 26.95M |
| AEON Biopharma | 26.82M |
| Exicure | 26.45M |